JD Health International Inc
HKEX:6618
JD Health International Inc
Cost of Revenue
JD Health International Inc
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
JD Health International Inc
HKEX:6618
|
Cost of Revenue
-¥36.8B
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
N/A
|
|
Vipshop Holdings Ltd
NYSE:VIPS
|
Cost of Revenue
-¥87.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-27%
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Cost of Revenue
-¥577B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-47%
|
|
Pinduoduo Inc
NASDAQ:PDD
|
Cost of Revenue
-¥91.7B
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-99%
|
CAGR 10-Years
N/A
|
|
Meituan
HKEX:3690
|
Cost of Revenue
-¥179.6B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
JD.Com Inc
HKEX:9618
|
Cost of Revenue
-¥925B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-31%
|
See Also
What is JD Health International Inc's Cost of Revenue?
Cost of Revenue
-36.8B
CNY
Based on the financial report for Dec 31, 2022, JD Health International Inc's Cost of Revenue amounts to -36.8B CNY.
What is JD Health International Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-55%
Over the last year, the Cost of Revenue growth was -57%. The average annual Cost of Revenue growth rates for JD Health International Inc have been -66% over the past three years , -55% over the past five years .